Soaring Demand Set to Propel Anticoccidial Drugs Market to $1.81 Billion by 2029

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Anticoccidial Drugs Market Through 2025?
In recent times, the anticoccidial drugs market has witnessed a robust expansion. The market is projected to rise from $1.27 billion in 2024 to $1.37 billion in 2025, progressing at a compound annual growth rate (CAGR) of 7.6%. The growth noted in the historical phase is credited to the escalated occurrences of coccidiosis worldwide, more people adopting pets, high coccidiosis prevalence, economic influence, and heightened safety concerns associated with food and animal health.

What's the Projected Size of the Global Anticoccidial Drugs Market by 2029?
In the coming years, the anticoccidial drugs market is projected to witness robust growth, reaching $1.81 billion in 2029, reflecting a compound annual growth rate (CAGR) of 7.2%. Factors contributing to this growth throughout the forecast period include the escalating number of veterinary healthcare institutions, increased incidence of coccidiosis in animals, a surge in the utilization of synthetic drugs, heightened demand for feed additives, and a rise in livestock production. The forecast period will be characterized by key trends such as the spike in demand due to newly emerging strains of coccidiosis, a pivot towards natural and substitute treatment approaches, intensified regulatory examination stimulating innovation, a growing consumer inclination towards poultry products free from antibiotics, progress in drug delivery technology, an increased emphasis on preventative healthcare strategies, and widening applications in aquaculture and pet animal sectors.

View the full report here:
https://www.thebusinessresearchcompany.com/report/anticoccidial-drugs-global-market-report

Top Growth Drivers in the Anticoccidial Drugs Industry: What's Accelerating the Market?
The escalating demand for protein sourced from meat is projected to fuel the expansion of the anticoccidial drug market. Meat proteins, which comprise of essential amino acids found naturally in animal tissue, are a critical component of various physiological processes. The surge in their demand can be attributed to factors such as population growth, urbanization, a rise in disposable income, and a shift in diet towards protein-rich food. To ensure that farmers can efficiently and sustainably keep up with the escalating demand for meat proteins, anticoccidial drugs have become a key resource in the contemporary livestock farming scene. This is exemplified by July 2023's report from the France-based Organization for Economic Co-operation and Development (OECD) and Italy-based Food and Agriculture Organization. According to the report, despite a projected 2% increase in global average per capita meat demand, from the 2020-2022 base period to 2032, the FAO meat price index jumped by 10% in 2022 due to decreased export supplies. Consequently, the burgeoning demand for meat proteins has been instrumental in driving the growth of the anticoccidial drug market. Growth in Poultry Farming Fuels Progress in Anticoccidial Drug Market

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15723&type=smp

What Trends Will Shape the Anticoccidial Drugs Market Through 2029 and Beyond?
Significant players in the anticoccidial drugs market are concentrating on creating trailblazing solutions, like synthetic coccidiostat, to boost efficiency, limit resistance progression, and handle emerging issues in poultry and farm animal management. Synthetic coccidiostat is an artificially developed compound for preventing or controlling coccidiosis through thwarting the coccidia parasites' growth and reproduction in animals. For example, Zoetis, an animal health company from the US, introduced Avi-Deccox, a restructured synthetic coccidiostat, intended for coccidiosis control in broiler chickens in 2023. The product specifically aims at the pathogens Eimeria acervulina and Eimeria tenella, the cause for considerable financial setbacks in poultry farming. The product comprises decoquinate as its active ingredient, akin to its predecessor Deccox. Avi-Deccox deals with increasing resistance issues tied to the repeated use of ionophores in poultry farming using an alternate mode of action, offering a more potent short-term knock-down impact.

What Are the Main Segments in the Anticoccidial Drugs Market?
The anticoccidial drugs market covered in this report is segmented -

1) By Drug Class: Ionophore, Antibiotic, Sulphonamides, Chemical Derivative, Other Drug Classes
2) By Drug Action: Coccidiostatic, Coccidiocidal
3) By Application: Poultry, Swine, Fish, Cattle, Companion Animals
4) By Distribution Channel: Veterinary Hospitals, Retail Pharmacy, Other Distribution Channels

Subsegments:
1) By Ionophore: Monensin, Lasalocid, Salinomycin
2) By Antibiotic: Tylosin, Lincomycin, Bacitracin
3) By Sulphonamides: Sulfadimethoxine, Sulfaquinoxaline
4) By Chemical Derivative: Diclazuril, Clopidol
5) By Other Drug Classes: Amprolium, Robenidine

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=15723&type=smp

Which Top Companies are Driving Growth in the Anticoccidial Drugs Market?
Major companies operating in the anticoccidial drugs market are Johnson & Johnson, Merck and Co. Inc., Bayer AG, Novartis AG, Eli Lilly and Company Ltd., Boehringer Ingelheim GmbH, Zoetis Inc., Elanco Animal Health Incorporated, Intas Pharmaceuticals Ltd., Ceva Santé Animale S.A., Virbac S.A., Phibro Animal Health Corporation, Vetoquinol SA, Alpharma BVBA, Kepro B.V., Kemin Industries Inc., Tianjin Ringpu Bio-Technology Co. Ltd., Hester Biosciences Limited, Huvepharma AD, Biovet S.A., Lallemand Animal Nutrition, HIPRA, Impextraco NV, Venkateshwara Hatcheries Pvt Ltd

Which Regions Will Dominate the Anticoccidial Drugs Market Through 2029?
North America was the largest region in the anticoccidial drugs market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anticoccidial drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15723

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.